Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2007
02/08/2007WO2007014433A1 Polysaccharide synthases
02/08/2007WO2007014415A1 Helminth antigen and immunotherapy
02/08/2007WO2006133182A3 Insect-specific protease recognition sequences
02/08/2007WO2006127452A3 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
02/08/2007WO2006094238A3 Compositions for use in identification of adventitious viruses
02/08/2007WO2006091841A3 Compositions and their uses directed to il-4r alpha
02/08/2007WO2006089294A3 Tissue specific expression of antibodies in chickens
02/08/2007WO2006085700A3 Pharmaceutical agents for preventing metastasis of cancer
02/08/2007WO2006076674A3 Deprotection and purification of oligonucleotides and their derivatives
02/08/2007WO2006067506A3 Hiv resistance genes
02/08/2007WO2006067487A3 Use of cytochrome p450 reductase as insecticidal target
02/08/2007WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
02/08/2007WO2006060484A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
02/08/2007WO2006050834A3 Antibodies against tenascin-c
02/08/2007WO2006005023A3 Promoter, promoter control elements and combinations, and uses thereof
02/08/2007WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
02/08/2007WO2005044987A3 Tocopherol associated protein and uses thereof
02/08/2007WO2005010161A3 Device and method to facilitate directed delivery and electroporation
02/08/2007WO2004108904A3 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
02/08/2007WO2004044124A3 Identification of oligoadenylate synthetase-like genes
02/08/2007WO2003068934A3 Chimeric molecules for cleavage in a treated host
02/08/2007WO2003059267A3 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF
02/08/2007US20070033678 Precise cutting
02/08/2007US20070033677 Plant sHSP gene bidirectional promoter and uses thereof
02/08/2007US20070033676 glucagon-like peptide-1 (GLP-1) which is peptidase-resistant; has resistance to trypsin; producing a plant storage organ in which the recombinant protein is highly produced
02/08/2007US20070033675 Brassica plants with high levels of anticarcinogenic glucosinolates
02/08/2007US20070033674 Flavanoid 3',5' hydroxylase gene sequences and uses therefor
02/08/2007US20070033673 Annexin and p34 promoters and use in expression of transgenic genes in plants
02/08/2007US20070033672 Inbred corn line BE9515
02/08/2007US20070033671 Polynucleotides and polypeptides in plants
02/08/2007US20070033670 Wheat plants having increased tolerance to imidazolinone herbicides
02/08/2007US20070033669 Semaphorin gene family
02/08/2007US20070033667 Method for the Production of Nuclear Transfer Embryos
02/08/2007US20070033666 Using cytosine deaminases to diminish retroelement transfer from pigs to humans
02/08/2007US20070033665 Unactivated oocytes as cytoplast recipients for nuclear transfer
02/08/2007US20070033664 Quiescent cell populations for nuclear transfer
02/08/2007US20070033663 ES cells having enhanced RNAi effect
02/08/2007US20070032963 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program
02/08/2007US20070032961 Apparatus and method for automated protein design
02/08/2007US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
02/08/2007US20070032639 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation
02/08/2007US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
02/08/2007US20070032446 Gapped 2' modified oligonucleotides
02/08/2007US20070032445 Antisense IAP nucleobase oligomers and uses thereof
02/08/2007US20070032442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells
02/08/2007US20070032441 treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
02/08/2007US20070032440 Oligonucleotides directed against a survivin gene and use thereof
02/08/2007US20070032439 Tarp promoter and uses thereof
02/08/2007US20070032406 Identification of novel nogo-receptors and methods related thereto
02/08/2007US20070031969 Bacteria with reduced genome
02/08/2007US20070031968 Beer yeast cell bodies containing high ribonucleic acid content and their production method
02/08/2007US20070031967 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031957 Extraction and purification of phosphodiesterase
02/08/2007US20070031951 Method for the production of resveratrol in a recombinant bacterial host cell
02/08/2007US20070031950 Production of D-lactic acid with yeast
02/08/2007US20070031948 Shuttle vectors; replicable in bacteria belonging to the genus Rhodococcus and E. coli; permit mass production of useful enzymes including aminoketone asymmetric reductases in transformants
02/08/2007US20070031947 Transgenic amorpha-4, 11-diene synthesis
02/08/2007US20070031946 Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine
02/08/2007US20070031945 High mannose proteins and methods of making high mannose proteins
02/08/2007US20070031943 System for manipulating nucleic acids
02/08/2007US20070031940 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
02/08/2007US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
02/08/2007US20070031937 Co-expression of recombinant proteins
02/08/2007US20070031936 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031935 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031934 Nucleic acid sequences having gene transcription regulatory qualities
02/08/2007US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences
02/08/2007US20070031932 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom
02/08/2007US20070031930 Includes lowering the pH of a whole E coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating the cellular debris from the released protein to obtain a protein product enriched in the heterologous target protein
02/08/2007US20070031929 Polypeptides Homologous To VEGF and BMP1
02/08/2007US20070031928 Glucoamylase variants
02/08/2007US20070031921 Potent combinations of mrna transport elements
02/08/2007US20070031920 High expression locus vector based on ferritin heavy chain gene locus
02/08/2007US20070031904 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031903 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031894 Novel nerve stem cell marker
02/08/2007US20070031890 Methods and compositions for diagnosing and monitoring transplant rejection
02/08/2007US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
02/08/2007US20070031885 Amplifying the target in a reaction mixture of a reporter oligonucleotide; a nucleic acid polymerase; and a pair of oligonucleotide primers, where at least one has at least one non-natural base; analyzing mutations; quantitative analysis; one pot process; simplification; efficiency; high speed; kinetics
02/08/2007US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules
02/08/2007US20070031880 Chemical treatment of biological samples for nucleic acid extraction and kits therefor
02/08/2007US20070031879 Novel enterokinase cleavage sequences
02/08/2007US20070031878 Methods and compositions for polypeptide engineering
02/08/2007US20070031877 Support for analyte determination methods and method for producing the support
02/08/2007US20070031864 Polyvalent cation-sensing receptor in atlantic salmon
02/08/2007US20070031860 G-protein coupled receptor and uses therefor
02/08/2007US20070031859 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
02/08/2007US20070031844 Functional and hyperfunctional siRNA
02/08/2007US20070031840 Nucleic acids specifically binding bioactive ghrelin
02/08/2007US20070031836 Altered Bacillus SecA comprising at least one amino acid change in IRA-1 and/or IRA-2 (intramolecular regulator of ATP hydrolysis)
02/08/2007US20070031832 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes
02/08/2007US20070031824 Simultaneous quantification of nucleic acids in diseased cells
02/08/2007US20070031823 Bioinformatically detectable group of novel vaccinia regulatory genes and uses thereof
02/08/2007US20070031478 Modified peptides and their uses
02/08/2007US20070031458 Recombinant Vibrio cholerae strain and vaccine comprising said strain
02/08/2007US20070031455 expression vector; comprise a recombinant avipox virus containing a Nipah virus glycoprotein gene; used for vaccinating pigs against Nipah
02/08/2007US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV)
02/08/2007US20070031444 Compounds targeted to cellular locations
02/08/2007US20070031442 Method and compositions for boosting immune response